当前位置: 首页 > 详情页

miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Burn and Reconstruction, the First Affliated Hospital of Zhengzhou University, Zhengzhou, China [2]Department of Endocrinology and Metabolism, the First Affliated Hospital of Zhengzhou University, Zhengzhou, China [3]Department of General Surgery, the Air Force General Hospital PLA, Beijing, China [4]Department of Traditional Chinese Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
出处:
ISSN:

关键词: MiR-506 cutaneous squamous cell carcinoma p65 LAMC1 apoptosis metastasis

摘要:
Previous research has shown that microRNA 506 (miR-506) functions as an essential modulator in the development of many biological reactions, including multiple cancers. However, its involvement in cutaneous squamous cell carcinoma (CSCC) has been rarely reported. In the present work, we investigated the molecular mechanism and function of miR-506 in the regulation of CSCC cell viability and metastasis (migration and invasion). We observed that miR-506 expression was upregulated in both CSCC tissues and cell lines, and that decreased miR-506 expression led to repressed tumorigenesis in CSCC cells. Furthermore, flow cytometry revealed that the depletion of miR-506 resulted in decreased proliferation and increased apoptotic levels in CSCC cells. Meanwhile, it was found that miR-506 decreased CSCC cell migration and invasion in vitro. The dual-luciferase reporter assay also revealed that miR-506 targets the 3 '-UTRs of p65 and Laminin C1 (LAMC1) for silencing. Silencing of p65 expression counteracted the pro-apoptotic influence of miR-506 depletion in CSCC cells, while inhibition of LAMC1 expression restored the migration and invasion properties of the CSCC cells. Therefore, the results provide evidence for the need to probe the biological and molecular mechanisms behind the development and progression of CSCC and may lead to novel treatment CSCC strategies.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 2 区 生物
小类 | 3 区 细胞生物学
最新[2023]版:
大类 | 3 区 生物学
小类 | 4 区 细胞生物学
JCR分区:
出版当年[2017]版:
Q3 CELL BIOLOGY
最新[2023]版:
Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Burn and Reconstruction, the First Affliated Hospital of Zhengzhou University, Zhengzhou, China
通讯作者:
通讯机构: [1]Department of Burn and Reconstruction, the First Affliated Hospital of Zhengzhou University, Zhengzhou, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院